Product NDC: | 59762-6002 |
Proprietary Name: | oxaprozin |
Non Proprietary Name: | OXAPROZIN |
Active Ingredient(s): | 600 mg/1 & nbsp; OXAPROZIN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59762-6002 |
Labeler Name: | Greenstone LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018841 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20130328 |
Package NDC: | 59762-6002-1 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (59762-6002-1) |
NDC Code | 59762-6002-1 |
Proprietary Name | oxaprozin |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (59762-6002-1) |
Product NDC | 59762-6002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | OXAPROZIN |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130328 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Greenstone LLC |
Substance Name | OXAPROZIN |
Strength Number | 600 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |